Global private equity and venture capital news and research

Posts Tagged ‘Bay City Capital’

9 January 2015

Rare disease drug developer Vtesse nets $25m NEA-led Series A

pharma pills drugs treatment New Enterprise Associates has led a $25m Series A financing round for rare disease drug developer Vtesse.

21 August 2014

Dermira raises $51m Series C from new and existing backers

skin Medical dermatology products maker Dermira has secured $51m in a Series C round backed by new and existing backers.

12 February 2014

VC backed Cadence Pharmaceuticals sells for $1.3bn

NYSE-listed pharmaceuticals company Mallinckrodt has agreed to acquire VC-backed Cadence Pharmaceuticals for $1.3bn.

9 October 2013

Bay City Capital brings in ex-MPM Capital managing director Ashley Dombkowski

Ashley Dombkowski Bay City Capital Life sciences-focused venture firm Bay City Capital has hired ex-MPM Capital managing director Ashley Dombkowski.

1 October 2013

Bay City Capital, Lundbeckfond latest venture investors in drug accelerator Cydan

drug pharma bottle Bay City Capital and Lundbeckfond Ventures have brought drug accelerator Cydan’s total funding to $26m by backing a new financing round.

21 June 2013

Aviir raises $10m from venture capital firms

Biotech company Aviir has received a third $10m investment from venture capital firms including new investors Partners & Partners and Merck Global Health Innovation Fund.

14 May 2013

Bay City Capital captures ex-Amgen executive David Beier as managing director

David Beier Bay City Capital Life sciences-focused venture firm Bay City Capital has hired experienced biotech operator David Beier as a managing director.

7 March 2013

VC firm Novo leads $48m round for Nevro Corp

news_biotech_lrg Venture capital firm Novo Ventures has thrown its support behind Nevro Corp by leading its sizeable $48m Series C funding round, which was also supported by peers Enterprise Associates and Covidien Ventures.

12 February 2013

US biotech developer Aviir inks $10m investment tranche

US biotechnology developer Aviir has confirmed the completion of its second $10m tranche of a total possible financing of $30m.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016